← Evidence map

ReviewCurrent hematologic malignancy reports2019

Is There a Role for Dose Modification of TKI Therapy in CML?

M CoplandPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31197525